S. Vincent Rajkumar, MD
Mayo Clinic
Latest Content
Second Line and Beyond
07/10/2026
Ep 4. Community Perspective: Partnerships and Outpatient Strategies for Bispecifics in Multiple Myeloma
Second Line and Beyond
07/09/2026
Ep 3. Managing Side Effects BCMA Bispecifics and Talquetamab in Myeloma
Second Line and Beyond
07/08/2026
Ep 2. The Advent of Bispecifics: MajesTEC-3, MajesTEC-9, and MonumenTAL-3
Second Line and Beyond
07/07/2026
Ep 1. The New Algorithm for Second-Line Treatment of Multiple Myeloma
Second Line and Beyond
06/26/2026
Evolving Treatment Landscape in Second-Line and Beyond Multiple Myeloma
Hematology
02/21/2026